Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases
Veterinary Clinical Pathology · 2024
DOI: 10.1111/vcp.13353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Clinical Pathology, 2024. Verfasst von N Koho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Dog Diseases, Biomarkers, Procalcitonin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terveyden Tutkimuksen Toimikunta.
Abstract (Originalsprache)
Background
Procalcitonin (PCT) is a useful biomarker in humans in the identification of bacterial respiratory infections.
Objectives
The aim of this study was to investigate the utility of serum PCT measurements as a diagnostic biomarker in canine bacterial lower respiratory tract diseases.
Methods
PCT concentrations were measured in serum samples with an ELISA method previously validated for dogs. All dogs underwent thorough clinical examinations, and the diagnosis of respiratory disease was based on clinical and laboratory findings, diagnostic imaging, as well as cytology and bacterial culture of respiratory samples. PCT concentrations between different cohorts of dogs were compared with an ANOVA‐model.
Results
Sixty‐two privately owned dogs with respiratory diseases, 25 with bacterial pneumonia (BP), 17 with bacterial bronchitis caused by Bordetella bronchiseptica (BB), and 20 with chronic bronchitis (CB) as well as 44 healthy controls were included in the study. Serum PCT concentrations in dogs with bacterial respiratory diseases (BP mean 51.8 ng/L ± standard deviation [SD] 40.6 ng/L and BB mean 61.4 ng/L ± SD 35.3 ng/L) were not significantly different when compared with dogs with a non‐bacterial respiratory disease (CB mean 89.7 ± SD 73.5 ng/L) or healthy dogs (mean 51.0 ng/L ± SD 37.5 ng/L, p > .05 in all comparisons).
Conclusions
These results indicate that despite being a valuable diagnostic, prognostic, and follow‐up marker in humans with pneumonia, serum PCT concentrations are not elevated in dogs with bacterial respiratory diseases and, therefore, cannot be used as a diagnostic biomarker in dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
ORCID-Profile: S J Viitanen
Förderung
- Terveyden Tutkimuksen Toimikunta
Zitieren
APA
Koho, N., Rajamäki, M. M., & Viitanen, S. J. (2024). Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases. Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.13353
Vancouver
Koho N, Rajamäki MM, Viitanen SJ. Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases. Veterinary Clinical Pathology. 2024. doi:10.1111/vcp.13353
BibTeX
@article{Koho2024,
author = {Koho, N and Rajamäki, M M and Viitanen, S J},
title = {Serum procalcitonin as a diagnostic biomarker in dogs with bacterial respiratory diseases},
journal = {Veterinary Clinical Pathology},
year = {2024},
doi = {10.1111/vcp.13353}
}
EUVIMED